{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T02:36:58Z","timestamp":1791599818540,"version":"4.3.4"},"reference-count":11,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","jns-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1016\/j.jns.2014.08.041","type":"journal-article","created":{"date-parts":[[2014,8,30]],"date-time":"2014-08-30T20:05:29Z","timestamp":1409429129000},"page":"353-355","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Reduced serum orexin-A levels in autoimmune encephalitis and neuromyelitis optica patients"],"prefix":"10.1016","volume":"346","author":[{"given":"Cem \u0130smail","family":"K\u00fc\u00e7\u00fckali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hazal","family":"Haytural","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00fcl\u00e7in","family":"Benbir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arzu","family":"\u00c7oban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Canan","family":"Ulusoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murat","family":"Giri\u015f","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murat","family":"K\u00fcrt\u00fcnc\u00fc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erkingul","family":"Shugaiv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derya","family":"Karadeniz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erdem","family":"T\u00fcz\u00fcn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jns.2014.08.041_bb0005","first-page":"1305","article-title":"Hypothalamic immunopathology in anti-Ma-associated diencephalitis with narcolepsy-cataplexy","volume":"70","author":"Dauvilliers","year":"2013","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.jns.2014.08.041_bb0010","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1093\/sleep\/30.6.767","article-title":"REM sleep behavior disorder and narcoleptic features in anti-Ma2-associated encephalitis","volume":"30","author":"Compta","year":"2007","journal-title":"Sleep"},{"key":"10.1016\/j.jns.2014.08.041_bb0015","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1212\/01.WNL.0000101718.92619.67","article-title":"Hypocretin-1 CSF levels in anti-Ma2 associated encephalitis","volume":"62","author":"Overeem","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2014.08.041_bb0020","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1001\/archneurol.2009.264","article-title":"Symptomatic narcolepsy in patients with neuromyelitis optica and multiple sclerosis: new neurochemical and immunological implications","volume":"66","author":"Kanbayashi","year":"2009","journal-title":"Arch Neurol"},{"key":"10.1016\/j.jns.2014.08.041_bb0025","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/ana.23577","article-title":"Morvan syndrome: clinical and serological observations in 29 cases","volume":"72","author":"Irani","year":"2012","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jns.2014.08.041_bb0030","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1002\/ana.1130","article-title":"Low cerebrospinal fluid hypocretin (Orexin) and altered energy homeostasis in human narcolepsy","volume":"50","author":"Nishino","year":"2001","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jns.2014.08.041_bb0035","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/935379","article-title":"Evaluation of incidence and clinical features of antibody-associated autoimmune encephalitis mimicking dementia","author":"\u00c7oban","year":"2014","journal-title":"Behav Neurol"},{"key":"10.1016\/j.jns.2014.08.041_bb0040","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1212\/01.wnl.0000216139.44259.74","article-title":"Revised diagnostic criteria for neuromyelitis optica","volume":"66","author":"Wingerchuck","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2014.08.041_bb0045","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.smrv.2007.04.001","article-title":"Diagnosis of narcolepsy and idiopathic hypersomnia. An update based on the International classification of sleep disorders, 2nd edition","volume":"11","author":"Billiard","year":"2007","journal-title":"Sleep Med Rev"},{"key":"10.1016\/j.jns.2014.08.041_bb0050","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0304-3940(01)02476-4","article-title":"Plasma orexin-A is lower in patients with narcolepsy","volume":"318","author":"Higuchi","year":"2002","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.jns.2014.08.041_bb0055","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/B978-0-12-394623-2.00011-1","article-title":"Glutamate and orexin neurons","volume":"89","author":"Eyigor","year":"2012","journal-title":"Vitam Horm"}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X14005735?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X14005735?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,30]],"date-time":"2018-09-30T05:27:53Z","timestamp":1538285273000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X14005735"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11]]},"references-count":11,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["S0022510X14005735"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2014.08.041","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reduced serum orexin-A levels in autoimmune encephalitis and neuromyelitis optica patients","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2014.08.041","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}